Condition

MDR-TB clinical trials and research

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• New six-month regimen for MDR-TB in France using BPaLM or BPaLC/BPaLM+Clofazimine

  This trial tests whether a six-month, bedaquiline-containing treatment strategy for rifampicin-resistant TB works as well as the long traditional regimens used in France by comparing outcomes to a historical cohort.

  Recruiting at 4 sites Phase 3 Assistance Publique - Hôpitaux de Paris · Amiens and 4 other locations · NCT07486024

• Immunotherapy for multidrug-resistant tuberculosis

  This study is testing a new immune therapy combined with standard TB treatment to see if it can help people with multidrug-resistant tuberculosis who haven't responded well to current medications.

  Recruiting at 2 sites Phase 4 Shanghai Pulmonary Hospital, Shanghai, China · Shanghai and 1 other locations · NCT05493267

Related topics

Quick answers

How many MDR-TB clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in France (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →